子宫内膜癌幸存者长期糖尿病风险:基于人群队列研究
该研究基于犹他州1997-2012年诊断的2314例子宫内膜癌患者与8583名一般人群女性,按出生年份和出生州匹配,利用电子病历和全州医疗机构数据库识别糖尿病诊断,采用Cox比例风险模型估计风险比。结果显示子宫内膜癌幸存者2型糖尿病风险显著高于一般人群,诊断后1年内HR=5.22,>1-5年HR=1.67,>5年HR=1.65;诊断时肥胖者风险增加三倍(HR=2.99)。结论提示应对子宫内膜癌幸存者进行长期糖尿病监测。
要点
- 子宫内膜癌幸存者2型糖尿病风险显著高于一般人群,诊断后1年内HR=5.22。
- 诊断时肥胖的子宫内膜癌患者2型糖尿病风险增加三倍(HR=2.99)。
- 癌症治疗似乎不增加糖尿病风险,但远处转移期患者糖尿病风险较高。
核心结论
- 子宫内膜癌幸存者糖尿病风险高于一般人群女性。
- 结果提示应对子宫内膜癌幸存者进行长期糖尿病监测。
研究设计与样本
- 基于人群的队列研究,纳入1997-2012年犹他州诊断的子宫内膜癌患者2314例,按出生年份和出生州匹配一般人群女性8583名。
- 糖尿病诊断通过电子病历和全州医疗机构数据库识别,采用Cox比例风险模型估计风险比。
主要发现
- 子宫内膜癌幸存者诊断后1年内2型糖尿病风险显著高于一般人群(HR=5.22,95%CI=4.05,6.71)。
- 诊断后>1-5年风险仍显著升高(HR=1.67,95%CI=1.31,2.12)。
- 诊断后>5年风险仍显著升高(HR=1.65,95%CI=1.29,2.11)。
- 诊断时肥胖的子宫内膜癌患者2型糖尿病风险增加三倍(HR=2.99,95%CI=2.59,3.45)。
- 远处转移期患者糖尿病风险较高,但癌症治疗似乎不增加糖尿病风险。
临床怎么用
- 研究结果提示对子宫内膜癌幸存者应进行长期糖尿病监测。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The majority of endometrial cancer patients are overweight or obese at cancer diagnosis. Obesity is a shared risk factor for both endometrial cancer and diabetes, but it is unknown whether endometrial cancer patients have increased diabetes risks. The aim of our study was to investigate diabetes risk among endometrial cancer patients. METHODS: Endometrial cancer patients diagnosed between 1997 and 2012 in Utah (n = 2,314) were identified. Women from the general population (n = 8,583) were matched to the cancer patients on birth year and birth state. Diabetes diagnoses were identified from electronic medical records and statewide healthcare facility databases. Cox proportional hazards models were used to estimate hazard ratios for diabetes after cancer diagnosis. RESULTS: Endometrial cancer survivors had a significantly higher risk of type II diabetes when compared to women from the general population in the first year after cancer diagnosis (HR = 5.22, 95% CI = 4.05, 6.71), >1-5 years after cancer diagnosis (HR = 1.67, 95% CI = 1.31, 2.12), and >5 years after cancer diagnosis (HR = 1.65, 95% CI = 1.29, 2.11). Endometrial cancer patients who were obese at cancer diagnosis had a three-fold increase in type II diabetes risk (HR = 2.99, 95%CI = 2.59, 3.45). Although endometrial cancer patients diagnosed at distant stage had a higher risk of diabetes, cancer treatment did not appear to contribute to any diabetes risks. CONCLUSIONS: In conclusion, endometrial cancer survivors had a higher risk of diabetes than women in the general population. These results suggest that long term monitoring for diabetes is indicated for endometrial cancer survivors.
引用
- Kim S, Park J, Chen Y, et al. Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study. Gynecol Oncol. 2019. PMID: 31839336. doi:10.1016/j.ygyno.2019.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。